Schwab M - Search Results

1

Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro.

Deubzer HE, Ehemann V, Kulozik AE, Westermann F, Savelyeva L, Kopp-Schneider A, Riester D, Schwab M, Witt O. Deubzer HE, et al. Among authors: schwab m. Cancer Lett. 2008 Jun 8;264(1):21-8. doi: 10.1016/j.canlet.2008.01.002. Epub 2008 Feb 8. Cancer Lett. 2008. PMID: 18262346

2

Genetic parameters of neuroblastomas.

Westermann F, Schwab M. Westermann F, et al. Among authors: schwab m. Cancer Lett. 2002 Oct 28;184(2):127-47. doi: 10.1016/s0304-3835(02)00199-4. Cancer Lett. 2002. PMID: 12127685 Review.

3

Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.

Paffhausen T, Schwab M, Westermann F. Paffhausen T, et al. Among authors: schwab m. Cancer Lett. 2007 May 18;250(1):17-24. doi: 10.1016/j.canlet.2006.09.010. Epub 2006 Dec 4. Cancer Lett. 2007. PMID: 17141950

4

Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.

Deubzer HE, Ehemann V, Westermann F, Heinrich R, Mechtersheimer G, Kulozik AE, Schwab M, Witt O. Deubzer HE, et al. Among authors: schwab m. Int J Cancer. 2008 Apr 15;122(8):1891-900. doi: 10.1002/ijc.23295. Int J Cancer. 2008. PMID: 18074352

5

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.

Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F. Eckerle I, et al. Among authors: schwab m. Cancer Lett. 2009 Nov 18;285(1):99-107. doi: 10.1016/j.canlet.2009.05.007. Epub 2009 Jun 3. Cancer Lett. 2009. PMID: 19497660

6

BRCA2: a genetic risk factor for breast cancer.

Schwab M, Claas A, Savelyeva L. Schwab M, et al. Cancer Lett. 2002 Jan 10;175(1):1-8. doi: 10.1016/s0304-3835(01)00752-2. Cancer Lett. 2002. PMID: 11734330 Review.

7

Low-frequency common fragile sites: link to neuropsychiatric disorders?

Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. Savelyeva L, et al. Among authors: schwab m. Cancer Lett. 2006 Jan 28;232(1):58-69. doi: 10.1016/j.canlet.2005.08.033. Epub 2005 Nov 17. Cancer Lett. 2006. PMID: 16298041 Review.

8

FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD).

Hormozian F, Schmitt JG, Sagulenko E, Schwab M, Savelyeva L. Hormozian F, et al. Among authors: schwab m. Cancer Lett. 2007 Feb 8;246(1-2):82-91. doi: 10.1016/j.canlet.2006.02.004. Epub 2006 Mar 23. Cancer Lett. 2007. PMID: 16556484

9

High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.

Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M. Westermann F, et al. Among authors: schwab m. Clin Cancer Res. 2007 Aug 15;13(16):4695-703. doi: 10.1158/1078-0432.CCR-06-2818. Epub 2007 Jul 25. Clin Cancer Res. 2007. PMID: 17652624

10

Suppression of polyploidy by the BRCA2 protein.

Sagulenko E, Savelyeva L, Ehemann V, Sagulenko V, Hofmann W, Arnold K, Claas A, Scherneck S, Schwab M. Sagulenko E, et al. Among authors: schwab m. Cancer Lett. 2007 Nov 8;257(1):65-72. doi: 10.1016/j.canlet.2007.07.003. Epub 2007 Aug 7. Cancer Lett. 2007. PMID: 17686574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,905 results

Search Page

Filters